Kolexia
Pages Franck
Biologie médicale
Hôpital Européen Georges Pompidou
Paris, France
127 Activités
4 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Tumeurs du côlon Récidive tumorale locale Métastase tumorale Tumeurs du rectum Mélanome Typhus murin Typhus épidémique à poux Tumeurs du poumon

Industries

VERACYTE
7 collaboration(s)
Dernière en 2022
BMS
5 collaboration(s)
Dernière en 2021
MSD
3 collaboration(s)
Dernière en 2020
AstraZeneca
2 collaboration(s)
Dernière en 2020

Dernières activités

COLOSAVE: Personalized Medicine in Early Stage Colorectal Cancer: Organ Preservation and Immune Benefit
Essai Clinique (Assistance publique – Hôpitaux de Paris)   14 février 2024
Reply to Z. Gao et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   02 février 2024
International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   03 octobre 2023
Multi-Institutional Evaluation of Pathologists' Assessment Compared to Immunoscore.
Cancers   10 août 2023
Évaluation de la composante immunitaire des cancers : actualités sur le test Immunoscore
Edimark   31 mars 2023
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer.
Cancers   08 janvier 2023
Determination of Interactive States of Immune Checkpoint Regulators in Lung Metastases after Radiofrequency Ablation.
Cancers   22 novembre 2022
Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study.
Cancers   06 septembre 2022
336P Prognostic and predictive value of Immunoscore in stage III colorectal cancer in the combined SCOT and IDEA-HORG studies
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
International validation of the Immunoscore-biopsy (ISB) to guide selection and monitoring of patients treated with watch-and-wait (WW) strategy for rectal cancer.
2022 ASCO Annual Meeting I   02 juin 2022